← Back to Clinical Trials
Recruiting NCT07197476

NCT07197476 Adolescent Stress and Substance Intervention Subsequent to Trauma

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07197476
Status Recruiting
Phase
Sponsor Rhode Island Hospital
Condition PTSD
Study Type INTERVENTIONAL
Enrollment 92 participants
Start Date 2026-03-03
Primary Completion 2027-04

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
ASSIST Video Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 92 participants in total. It began in 2026-03-03 with a primary completion date of 2027-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The long-term goal of this study is to address the adoption of the new trauma center requirement to establish best practices of screening for acute stress with an intervention to prevent both adolescent PTSD and substance use. The investigators will develop, refine, and pilot test the Adolescent Stress and Substance Intervention Subsequent to Trauma (ASSIST) video interventions that build upon the American College of Surgeons Committee on Trauma guidelines to improve mental health care during and after hospitalization for traumatic injury. The aims are: PHASE I - Primary Aim 1: To develop and refine two ASSIST video interventions for adolescents and parents admitted to a level 1 pediatric trauma center. PHASE II * Primary Aim 2a: To evaluate the feasibility, acceptability and implementation potential of the ASSIST video interventions. * Primary Aim 2b: Develop the ASSIST implementation protocol using a national advisory panel of pediatric trauma center leaders. Participants in PHASE 1: Parent and child duo: * Review storyboards for the video interventions * Participate in qualitative interviews at hospital admission and 1 month following discharge Pediatric trauma center clinical staff members: \- Complete qualitative interviews Participants in PHASE II: Parent and child duo: * Shown their own video interventions * Complete assessments at admission and 1-, 2-, 3- months after discharge

Eligibility Criteria

Inclusion Criteria for Youth: * Must be 12-17 years * Fluent in English or Spanish * Able to provide informed assent * Have a parent able to provide informed consent Inclusion Criteria for Parents: * Live with an admitted pediatric trauma patient * Fluent in English or Spanish * Able to provide informed consent Exclusion Criteria: * Prisoner or in police custody * Involvement with child protective services * Admitted due to suicide attempt or non-suicidal self-injury * Any acute condition that would preclude provision of informed consent or assent

Frequently Asked Questions

Who can join the NCT07197476 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07197476 currently recruiting?

Yes, NCT07197476 is actively recruiting participants. Visit ClinicalTrials.gov or contact Rhode Island Hospital to inquire about joining.

Where is the NCT07197476 trial being conducted?

This trial is being conducted at Providence, United States.

Who is sponsoring the NCT07197476 clinical trial?

NCT07197476 is sponsored by Rhode Island Hospital. The trial plans to enroll 92 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology